A new test can quickly test the ability of antibodies to neutralize spike proteins from different variants of COVID-19 simultaneously. The D4 assay shown here is the Teflon-like technology that makes the test possible.

The stress and isolation of the pandemic may have a lasting toll on some children, but Duke experts say most will recover fully — and some might even emerge with new strengths.

Vaccines are our best defense against COVID-19 and its variants. Protect yourself and others - don’t wait to vaccinate!

Dr. Charlene Wong works to improve and protect the health of the community

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

In a virtual media briefing with reporters, Dr. Emmanuel Walter Jr., discussed his study findings, the overall vaccine trial process, potential side effects, and the need for herd immunity in American communities.

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

In many ways, the COVID-19 pandemic forced positive changes in how medicine is practiced in communities and at academic medical centers, with Family Medicine departments working at the front lines

DURHAM, N.C.

The widespread use of masks in schools can effectively prevent COVID-19 transmission and provide a safe learning environment, two Duke scholars said Wednesday.